Part of Phaidon International
Part of Phaidon International
Showing 44 results
Sort by:
Role: VP of Quality Location: Boston, MA (On-site)Salary: $250k-$350kEPM Scientific is partnering with a rapidly growing structural heart medical device company that is advancing innovative therapies for patients with complex cardiovascular conditions. Following significant clinical progress, strong investor backing, and continued organizational gr...
Oncology Account ManagerTerritory: MA, NH, RI, ME, and parts of Upstate NYCompany: Midsized Pharmaceutical Company Role OverviewA midsized pharmaceutical company is seeking a dedicated Oncology Account Manager to cover their Boston territory. This role is pivotal in driving sales and establishing strong relationships with key thought leaders and pr...
Support oncology clinical development programs, initially focused on prostate cancer with exposure to additional solid tumor studiesLead clinical data review, analysis, and medical monitoring activities to support study execution and patient safetyContribute to key clinical and regulatory deliverables, including protocols, CSRs, IBs, and regulatory...
Take the first step toward your next opportunity - submit your resume and get started today.
Principal Engineer, Process Development & Scale-UpLocation: Greater Boston Area Base Salary Range: $145,000-$170,000 SummaryWe are currently partnered with a growing life sciences organization developing an innovative combination-product platform.The organization is seeking a Principal Engineer, Process Development & Scale-Up to lead the developmen...
Publications Manager / Scientific Lead, Medical CommunicationsLocation: Boston, MA or New York, NYWork Arrangement: Hybrid EPM Scientific is partnering with an independent global healthcare communications consultancy specializing in medical communications, market access, and HEOR. Due to continued demand from new and existing biopharmaceutical clie...
Role: Senior IT Business Analyst, GxP SystemsLocation: Boston, MASalary: $115k - $170k EPM is partnered with a clinical-stage biotechnology company developing next-generation genetic medicines for serious diseases. Leveraging a proprietary RNA-based platform, the organization is advancing multiple clinical and preclinical programs while continuing ...